IL-10 rs1800896 polymorphism predicts biochemical remission in IBD patients undergoing biologic therapy
IL-10 rs1800896基因多态性可预测接受生物制剂治疗的炎症性肠病(IBD)患者的生化缓解情况
专题命中 诊断辅助 :diagnosis(abstract);分类 q-bio
AI总结 该研究纳入197例接受靶向治疗的IBD患者,分析4种细胞因子基因SNP与临床表型及治疗应答的关联,发现IL-10 rs1800896变异等位基因可预测患者12个月时的生化缓解,支持IBD个性化治疗
Comments 22 pages; 2 main tables and 1 main figure; supplementary tables and figure included. Pre-peer-reviewed author manuscript. The final article was published in Immunology, 2026, volume 177, issue 2, pages 432-438
Journal ref Immunology. 2026;177(2):432-438